These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 17637391
1. Irradiation of human prostate cancer cells increases uptake of antisense oligodeoxynucleotide. Anai S, Brown BD, Nakamura K, Goodison S, Hirao Y, Rosser CJ. Int J Radiat Oncol Biol Phys; 2007 Jul 15; 68(4):1161-8. PubMed ID: 17637391 [Abstract] [Full Text] [Related]
2. Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response. Loriot Y, Mordant P, Brown BD, Bourhis J, Soria JC, Deutsch E. Anticancer Res; 2010 Oct 15; 30(10):3869-78. PubMed ID: 21036697 [Abstract] [Full Text] [Related]
3. Combination bcl-2 antisense and radiation therapy for nasopharyngeal cancer. Yip KW, Mocanu JD, Au PY, Sleep GT, Huang D, Busson P, Yeh WC, Gilbert R, O'Sullivan B, Gullane P, Bastianutto C, Liu FF. Clin Cancer Res; 2005 Nov 15; 11(22):8131-44. PubMed ID: 16299246 [Abstract] [Full Text] [Related]
4. Bcl-XL antisense oligonucleotides coupled with antennapedia enhances radiation-induced apoptosis in pancreatic cancer. Masui T, Hosotani R, Ito D, Kami K, Koizumi M, Mori T, Toyoda E, Nakajima S, Miyamoto Y, Fujimoto K, Doi R. Surgery; 2006 Aug 15; 140(2):149-60. PubMed ID: 16904964 [Abstract] [Full Text] [Related]
6. Sodium selenite radiosensitizes hormone-refractory prostate cancer xenograft tumors but not intestinal crypt cells in vivo. Tian J, Ning S, Knox SJ. Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):230-6. PubMed ID: 20615620 [Abstract] [Full Text] [Related]
7. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C. Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025 [Abstract] [Full Text] [Related]
9. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line. Gong ZB, Liu JM, Li YM. Hepatobiliary Pancreat Dis Int; 2005 Aug 01; 4(3):433-6. PubMed ID: 16109531 [Abstract] [Full Text] [Related]
10. Enhanced radiosensitivity by inhibition of the anti-apoptotic gene clusterin using antisense oligodeoxynucleotide in a human bladder cancer model. Yamanaka K, Gleave M, Muramaki M, Hara I, Miyake H. Oncol Rep; 2005 May 01; 13(5):885-90. PubMed ID: 15809754 [Abstract] [Full Text] [Related]
11. High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta(1) integrin expression. Simon EL, Goel HL, Teider N, Wang T, Languino LR, Fitzgerald TJ. Prostate; 2005 Jun 15; 64(1):83-91. PubMed ID: 15651037 [Abstract] [Full Text] [Related]
12. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice]. Zhang Y, Ma Y, Lu HP, Zhou XF, Xie Y, Gao JH, Liang CS. Zhonghua Yi Xue Za Zhi; 2008 Jul 29; 88(29):2073-6. PubMed ID: 19080439 [Abstract] [Full Text] [Related]
13. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer. Narita S, So A, Ettinger S, Hayashi N, Muramaki M, Fazli L, Kim Y, Gleave ME. Clin Cancer Res; 2008 Sep 15; 14(18):5769-77. PubMed ID: 18794086 [Abstract] [Full Text] [Related]
14. Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts. Anai S, Goodison S, Shiverick K, Hirao Y, Brown BD, Rosser CJ. Mol Cancer Ther; 2007 Jan 15; 6(1):101-11. PubMed ID: 17237270 [Abstract] [Full Text] [Related]
15. Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation. Cao W, Yacoub S, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C, Rosser CJ. Prostate; 2008 Aug 01; 68(11):1223-31. PubMed ID: 18465755 [Abstract] [Full Text] [Related]
16. Pharmacokinetics, toxicity, and efficacy of ends-modified raf antisense oligodeoxyribonucleotide encapsulated in a novel cationic liposome. Gokhale PC, Zhang C, Newsome JT, Pei J, Ahmad I, Rahman A, Dritschilo A, Kasid UN. Clin Cancer Res; 2002 Nov 01; 8(11):3611-21. PubMed ID: 12429653 [Abstract] [Full Text] [Related]
17. Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts. Agemy L, Harmelin A, Waks T, Leibovitch I, Rabin T, Pfeffer MR, Eshhar Z. Prostate; 2008 Apr 01; 68(5):530-9. PubMed ID: 18247403 [Abstract] [Full Text] [Related]
18. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. Zhang Y, Ma Y, Lu HP, Gao JH, Liang CS, Liu CZ, Zou JT, Wang HQ. Chin Med J (Engl); 2008 Nov 20; 121(22):2284-9. PubMed ID: 19080333 [Abstract] [Full Text] [Related]
19. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Butler M, Stecker K, Bennett CF. Lab Invest; 1997 Oct 20; 77(4):379-88. PubMed ID: 9354772 [Abstract] [Full Text] [Related]
20. Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization. Anai S, Shiverick K, Medrano T, Nakamura K, Goodison S, Brown BD, Rosser CJ. Urology; 2007 Oct 20; 70(4):832-7. PubMed ID: 17991582 [Abstract] [Full Text] [Related] Page: [Next] [New Search]